Total (%), n = 101 | G-I-N NA alone (%), n = 7 | G-I-N NA + NGC (%), n = 14 | NGC alone (%), n = 80 | |
---|---|---|---|---|
Posts protocol for public comment | No: 95 (94%) | No: 7 (100%) | No: 12 (86%) | No: 76 (95%) |
Sometimes: 3 (3%) | Sometimes: 0 (0%) | Sometimes: 2 (14%) | Sometimes: 1 (1%) | |
Yes: 3 (3%) | Yes: 0 (0%) | Yes: 0 (0%) | Yes: 3 (4%) | |
Obtains external review of draft guideline | No: 43% | No: 1 (14%) | No: 3 (21%) | No: 39 (49%) |
Sometimes: 6 (6%) | Sometimes: 1 (14%) | Sometimes: 1 (7%) | Sometimes: 4 (5%) | |
Yes: 52 (51%) | Yes: 5 (71%) | Yes: 10 (71%) | Yes: 37 (46%) | |
Patients represented in external review of draft guideline | No or uncertain: 88 (77%) | No or uncertain: 6 (86%) | No: 12 (86%) | No: 70 (87.5%) |
Sometimes: 6 (6%) | Sometimes: 0 (0%) | Sometimes: 2 (14%) | Sometimes: 4 (5%) | |
Yes: 7 (7%) | Yes: 1 (14%) | Yes: 0 (0%) | Yes: 6 (7.5%) | |
Posts draft guideline for public comment | No: 75 (74%) | No: 4 (57%) | No: 8 (57%) | No: 63 (79%) |
Sometimes: 2 (2%) | Sometimes: 0 (0%) | Sometimes: 1 (7%) | Sometimes: 1 (1%) | |
Yes: 24 (24%) | Yes: 3 (43%) | Yes: 5 (36%) | Yes: 16 (20%) | |
Patients represented in external review OR public comment | No or uncertain: 68 (67%) | No or uncertain: 3 (43%) | No or uncertain: 7 (50%) | No or uncertain: 58 (72.5%) |
Yes (at least sometimes): 33 (33%) | Yes (at least sometimes): 4 (57%) | Yes (at least sometimes): 7 (50%) | Yesa (at least sometimes): 22 (27.5%) |